SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001651308-21-000223
Filing Date
2021-11-04
Accepted
2021-11-04 16:44:05
Documents
97
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20210930.htm   iXBRL 10-Q 2870079
2 EX-31.1 exhibit311-2021q3.htm EX-31.1 10060
3 EX-31.2 exhibit312-2021q3.htm EX-31.2 10052
4 EX-32.1 exhibit321-2021q3.htm EX-32.1 6461
  Complete submission text file 0001651308-21-000223.txt   11002028

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20210930.xsd EX-101.SCH 75988
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20210930_cal.xml EX-101.CAL 90657
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20210930_def.xml EX-101.DEF 365334
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20210930_lab.xml EX-101.LAB 783421
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20210930_pre.xml EX-101.PRE 554445
10 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20210930_htm.xml XML 1886050
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 211380588
SIC: 2834 Pharmaceutical Preparations